Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Alembic Pharmaceuticals receives an EIR for its oncology formulation facility
According to the company’s statement, all EIRs are in place for their USFDA facilities
Results show potential of J&J’s TAR-210 to transform treatment of bladder cancer with FGFR…
Phase 1 trial shows 90 per cent recurrence-free survival and 90 per cent complete response in patients with high-risk and…
Lupin launches biosimilar Etanercept in Canada
Rymti is indicated for the treatment of moderate to severe active rheumatoid arthritis, juvenile idiopathic arthritis, active and…
DP World establishes new warehouse in Goa
The facility is compliant with all safety standards and provides connectivity to the Goa-Bangalore-Pune highway
Naprod renews EU-GMP certification for Palghar facility
The audit was conducted in December 2023 by The National Institute of Pharmacy and Nutrition (OGYÉI), Hungary
Emcure unveils campaign ‘Cure and Beyond’
The new corporate campaign featuring MS Dhoni aims to support, and educate people
WHO, THSTI launch e-learning course on rational use of medicines for pharmacists
This course comprises various modules such as the basic concept of rational use of Medicines, pharmacy practice regulation and…
Bayer secures full ownership of Bayer Zydus Pharma, acquires remaining 25 per cent stakes
The 50:50 joint venture was established on January 28, 2011, for the sales and marketing of pharmaceutical products in India
Akums introduces DCGI approved FDC medication
Amlodipine, Telmisartan & Metoprolol (ER) film coated tablets for treatment of resistant Hypertension
AbbVie and Sightsavers collaborate to raise awareness on Glaucoma in India
The campaign seeks to educate the public about risk factors associated with glaucoma, and promote regular eye check-ups,…